Rosenblatt Maintains Buy on Imax, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel maintains a Buy rating on Imax (NYSE:IMAX) and raises the price target from $25 to $28.
July 26, 2024 | 4:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel maintains a Buy rating on Imax and raises the price target from $25 to $28.
The Buy rating and increased price target from a reputable analyst are likely to positively influence investor sentiment and drive short-term price appreciation for IMAX.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100